Past Bid Detail | BidFortune

Past Bid Detail Page

Hi,

Federal Bid

Last Updated on 02 Oct 2020 at 3 AM

Combined Synopsis/Solicitation

Beltsville Maryland

Food and Drug Administration Broad Agency Announcement (BAA) for the Advanced Research and Development of Regulatory Science - Amendment 2

Solicitation ID FDABAA-20-00123

Source Signup to get source link

Posted Date 17 Jan 2020 at 8 PM

Archive Date 01 Oct 2020 at 4 AM

NAICS Category

Product Service Code

Set Aside No Set-Aside Used

Contracting Office Fda Office Of Acq Grant Svcs

Agency Department Of Health And Human Services

Location Beltsville Maryland United states 20705

Amendment 2

The purpose of this amendment is to: correct the reference in Research Area of Interest 7.3.2. Please see attached document entitled FDABAA-20-00123 - Amendment 2 for the most current version of the FDA's Broad Agency Announcement.

The White Paper due date remains unchanged at March 2, 2020, 5:00pm EST.

Amendment 1

The purpose of this amendment is to: provide the FDA's updated research areas of interest; provide additional information regarding proposal instructions; and, change the White Paper due date from March 13, 2020, to March 2, 2020.

Please see the attached document entitled FDABAA-20-00123 - Amendment 1 for the most current version of the FDA's Broad Agency Announcement.

Original Description

The Food and Drug Administration (FDA) solicits for advanced research and development proposals to support regulatory science and innovation. The FDA anticipates that research and development activities under this Broad Agency Announcement (BAA) will serve to advance scientific knowledge to accomplish its mission to protect and promote the health of our nation.

*This announcement is a renewal of the FY19 announcement (FDABAA-19-00123) and will remain open until further notice. It is renewed on an annual basis.

Bid Protests Not Available